Time has come.
When a person suffers a cardiac arrest, it is still generally assumed that within a few minutes first the brain and then also the other organs are so severely damaged that there is a narrow time frame beyond which there is as small chance of successful resuscitation.
The Next Level of ECPR.
Personalized and Controlled Resuscitation.
To shift the Limits.
Recent research shows that this assumption is not true: The organs and also the brain can survive much longer without the supply of oxygen. But the entire body is in a special state that must be understood very precisely and treated on a patient-specific basis.
CARL is designed for this particular patient state after cardiac arrest and aims to push the current limits of resuscitation by improving neurological-intact survival through individualized and targeted resuscitation.
CARL. The Next Level of ECPR.
CARL Therapy focuses on controlled reperfusion during extracorporeal resuscitation (ECPR), in which key vital parameters are monitored on a patient- and situation-specific basis, thereby potentially increasing the chance of neurologically intact survival. To ensure the optimal application of the therapy, the CARL Technology was developed specifically for resuscitation use. All-day clinical support as well as an extensive training program through the CARL Academy are available online or at on-site facilities to clinical users at all times.